Law Blog - WSJ.com (Free subscription) | 3 hours ago
The family of a California woman who went into respiratory arrest and died after neck surgery filed a lawsuit blaming her death on the use of a fast-selling bone-growth protein made by Medtronic Inc.The case of Shirley Nisbet comes amid a Justice Department investigation and a separate U.S. Senate inquiry into use of the bone-growth product -- called Infuse Bone Graft --...
Market Wire - Pharmaceuticals and Biotech: Biotech (Free subscription) | yesterday
ROCKVILLE, MD (MARKET WIRE) BioSurface Engineering Technologies, Inc. [BioSET], a privately held company developing synthetic peptide growth factor mimetics for advanced tissue repair, reported today that two pilot clinical trials, one in the United States and one in Canada, have been initiated with the Company's AMPLEX osteo-promotive bone graft system. AMPLEX is a novel combination medical device...
Business Wire (Free subscription) | yesterday
... revision and extremities markets. Our near-term commercial business is based on our VITOSS® Bone Graft Substitute technology platforms, which are designed to address the non-structural bone graft market by offering synthetic alternatives to the use of autograft or cadaver-based bone material, VITAGEL® Surgical Hemostat, which is an adherent matrix and an...
The Earth Times Online Newspaper (Free subscription) | yesterday
... revision and extremities markets. Our near-term commercial business is based on our VITOSS® Bone Graft Substitute technology platforms, which are designed to address the non-structural bone graft market by offering synthetic alternatives to the use of autograft or cadaver-based bone material, VITAGEL® Surgical Hemostat, which is an adherent matrix and an...
